Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Filspari®...
U.S. Suicide Rates Rise in Less Affluent Areas
An analysis of where suicides are occurring in the United States shows that, tragically, location matters. People living in poorer areas with fewer resources...
No Advantage Seen With Long-Term Oxygen Therapy for 24 Versus 15 Hours/Day
For patients starting long-term oxygen therapy for chronic, severe hypoxemia at rest, the risk for hospitalization or death within one year is comparable...
Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years
For adults aged 30 to 49 years, there has been a decline in melanoma incidence and mortality, according to a study published online Sept. 8 in JAMA Dermatology...
Low-Dose Triple-Pill Protocol Lowers BP in Black Africans With Hypertension
For Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieves better blood pressure lowering and control than standard...
Diabetes, Prediabetes Tied to Accelerated Brain Aging
Diabetes and prediabetes are associated with accelerated brain aging and potential dementia, according to a study published online Aug. 28 in Diabetes...
Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes
INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin efsitora...
Asthma Could Raise Miscarriage, Infertility Risks for Women: Study
Having asthma appears linked to raised odds for miscarriage and troubles with fertility among women, new Danish research shows. “We found that women...
Pandemic Isolation May Have Caused Rapid Brain Aging in Teen Girls
New research uncovers a possible reason why teenaged girls struggled so mightily with their mental health during the pandemic: Scans showed their brains...
Could Sulthiame, a Pill Approved in Europe for Epilepsy, Help Ease Sleep Apnea?
A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame had few pauses in their breathing...
First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma
HOUSTON, Sept. 9, 2024. Moleculin Biotech, Inc., ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio...
FDA Warns Consumers Not to Purchase or Use Umary and Amazy Products As They May Be Harmful To Your Health
FDA is warning consumers not to purchase or use Umary and Amazy products, marketed as dietary supplements, as they may be harmful to your health. This...
3-in-1 Blood Pressure Pill Could Be Treatment Advance
An experimental three-in-one blood pressure pill works better than layering on meds one at a time, a new clinical trial shows. After a month on the combo...
Recently Added
Recently added consumer and prescribing information: Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir, Epysqli, Pyzchiva, Ahzantive, Ohtuvayre, Sofdra
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Pavblu Pavblu (aflibercept-ayyh) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
- Lazcluze Lazcluze (lazertinib) is a kinase inhibitor used in combination with amivantamab for the treatment of certain patients with epidermal...
- Niktimvo Niktimvo (axatilimab-csfr) is a colony stimulating factor-1 receptor (CSF-1R)-blocking antibody used for the treatment of chronic...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...